In this review, we evaluate both the established and novel protein–protein interactions (PPIs) for CRP with an emphasis on discerning the network of interactions that underly CRP’s role in modulating tumor development, progression, and treatment resistance. The gene discussed is CRP; the disease is neoplasm.